[{"address1": "2 Holzman Street", "address2": "Science Park PO Box 4081", "city": "Rehovot", "zip": "7670402", "country": "Israel", "phone": "972 8 940 6472", "fax": "972 8 940 6473", "website": "https://www.kamada.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Kamada Ltd. manufactures and sells plasma-derived protein therapeutics. Its products include KAMRAB/KEDRAB indicated as prophylaxis of rabies; CYTOGAM for prophylaxis of Cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplants; VARIZIG for post exposure prophylaxis of varicella; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; GLASSIA for intravenous AATD; KAMRHO (D) IM for prophylaxis of hemolytic disease of newborns; and Echis coloratus and Vipera palaestinae Antiserum to treat snake bite. The company also distributes biopharmaceutical products in Israel, including BRAMITOB to manage chronic pulmonary infection; FOSTER to treat asthma; TRIMBOW for chronic obstructive pulmonary disease; PROVOCHOLINE for the diagnosis of bronchial airway hyperactivity; AEROBIKA, an OPEP device; RUPAFIN and RUPAFIN ORAL SOLUTION for allergic rhinitis and Urticaria; SINTREDIUS for rheumatoid arthritis, systemic lupus erythematosus, and mild-moderate juvenile dermatomyositis; IVIG for various immunodeficiency-related conditions; VARITECT for chicken pox and zoster herpes; ZUTECTRA and HEPATECT CP for prevention of hepatitis B; MEGALOTECT CP for CMV virus; RUCONEST for angioedema attack; HEPARIN SODIUM INJECTION for thrombo-embolic disorders and prophylaxis of deep vein thrombosis and thromboembolic events; ALBUMIN and ALBUMIN for blood plasma; Factor VIII for hemophilia type A; and Factor IX for hemophilia type B. In addition, it distributes COAGADEX to treat hereditary factor X deficiency; IXIARO for Japanese encephalitis; VIVOTIF for salmonella typhi; PROCYSBI for nephropathic cystinosis; LAMZEDE for alpha-mannosidosis; RYPLAZIM for hypoplasminogenemia; ELIGARD for prostate cancer; and BEVACIZUMAB KAMADA for various cancers. The company was incorporated in 1990 and is headquartered in Rehovot, Israel.", "fullTimeEmployees": 420, "companyOfficers": [{"maxAge": 1, "name": "Mr. Amir  London", "age": 55, "title": "Chief Executive Officer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 674000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Chaime  Orlev", "age": 54, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 478000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eran  Nir", "age": 51, "title": "Chief Operating Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 417000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jon R. Knight", "age": 58, "title": "Vice President of US Commercial Operations", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 302000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Boris  Gorelik", "age": 42, "title": "Vice President of Business Development & Strategic Programs", "yearBorn": 1982, "fiscalYear": 2024, "totalPay": 392000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Tsur", "age": 74, "title": "Co-Founder & Independent Deputy Chairman of the Board", "yearBorn": 1950, "fiscalYear": 2024, "totalPay": 252000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nir  Livneh B.A., L.L.B.", "age": 44, "title": "VP, General Counsel & Corporate Secretary", "yearBorn": 1980, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Hanni  Neheman", "age": 54, "title": "Vice President of Marketing & Sales", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Liron  Reshef", "age": 52, "title": "Vice President of Human Resources", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Shavit  Beladev", "title": "Vice President of Kamada Plasma", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.045, "open": 7.11, "dayLow": 7.11, "dayHigh": 7.28, "regularMarketPreviousClose": 7.045, "regularMarketOpen": 7.11, "regularMarketDayLow": 7.11, "regularMarketDayHigh": 7.28, "exDividendDate": 1742169600, "payoutRatio": 0.0, "beta": 0.11, "trailingPE": 22.4375, "forwardPE": 23.16129, "volume": 21474, "regularMarketVolume": 21474, "averageVolume": 63877, "averageVolume10days": 56100, "averageDailyVolume10Day": 56100, "bid": 5.19, "ask": 9.21, "bidSize": 2, "askSize": 2, "marketCap": 412885888, "fiftyTwoWeekLow": 5.17, "fiftyTwoWeekHigh": 9.15, "priceToSalesTrailing12Months": 2.4356608, "fiftyDayAverage": 7.46, "twoHundredDayAverage": 6.84635, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 352812160, "profitMargins": 0.11215, "floatShares": 9208085, "sharesOutstanding": 57505000, "sharesShort": 47250, "sharesShortPriorMonth": 138981, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.0008, "heldPercentInsiders": 0.07195, "heldPercentInstitutions": 0.49174, "shortRatio": 0.94, "shortPercentOfFloat": 0.0015, "impliedSharesOutstanding": 58020000, "bookValue": 4.582, "priceToBook": 1.5670013, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "earningsQuarterlyGrowth": 0.667, "netIncomeToCommon": 19011000, "trailingEps": 0.32, "forwardEps": 0.31, "enterpriseToRevenue": 2.081, "enterpriseToEbitda": 9.177, "52WeekChange": 0.25524473, "SandP52WeekChange": 0.1513431, "lastDividendValue": 0.2, "lastDividendDate": 1742169600, "quoteType": "EQUITY", "currentPrice": 7.18, "targetHighPrice": 20.0, "targetLowPrice": 11.0, "targetMeanPrice": 14.0, "targetMedianPrice": 12.5, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 65985000, "totalCashPerShare": 1.163, "ebitda": 38445000, "totalDebt": 11415000, "quickRatio": 2.211, "currentRatio": 4.004, "totalRevenue": 169516992, "debtToEquity": 4.391, "revenuePerShare": 2.946, "returnOnAssets": 0.043860003, "returnOnEquity": 0.07439, "grossProfits": 73943000, "freeCashflow": 19251250, "operatingCashflow": 40119000, "earningsGrowth": 0.625, "revenueGrowth": 0.054, "grossMargins": 0.4362, "ebitdaMargins": 0.22679001, "operatingMargins": 0.158, "financialCurrency": "USD", "symbol": "KMDA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "regularMarketChangePercent": 1.91625, "regularMarketPrice": 7.18, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1370007000000, "postMarketChangePercent": 0.0, "postMarketPrice": 7.18, "postMarketChange": 0.0, "regularMarketChange": 0.135, "regularMarketDayRange": "7.11 - 7.28", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 63877, "fiftyTwoWeekLowChange": 2.0099998, "fiftyTwoWeekLowChangePercent": 0.38878137, "fiftyTwoWeekRange": "5.17 - 9.15", "fiftyTwoWeekHighChange": -1.9699998, "fiftyTwoWeekHighChangePercent": -0.21530053, "fiftyTwoWeekChangePercent": 25.524473, "dividendDate": 1743984000, "earningsTimestamp": 1755057600, "earningsTimestampStart": 1755057600, "earningsTimestampEnd": 1755057600, "earningsCallTimestampStart": 1755088200, "earningsCallTimestampEnd": 1755088200, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 0.32, "epsForward": 0.31, "epsCurrentYear": 0.3825, "priceEpsCurrentYear": 18.771242, "shortName": "Kamada Ltd.", "longName": "Kamada Ltd.", "corporateActions": [], "postMarketTime": 1755893404, "regularMarketTime": 1755892801, "exchange": "NMS", "messageBoardId": "finmb_9002466", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "fiftyDayAverageChange": -0.2800002, "fiftyDayAverageChangePercent": -0.03753354, "twoHundredDayAverageChange": 0.33364964, "twoHundredDayAverageChangePercent": 0.048733942, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "displayName": "Kamada", "trailingPegRatio": 0.8053, "__fetch_time": "2025-08-23"}]